Therapeutic Antibodies – News and Features

Researchers at LJI and Columbia University uncover exactly how a neutralizing antibody blocks measles virus infection

In this article, we explore how mass spectrometry imaging technology is evolving into a high-resolution spatial biology toolset to transform drug discovery and development.

Researchers develop fully human antibodies that can neutralize the alpha-latrotoxin of the European black widow, potentially reducing the need for antibodies derived from horses to treat disease caused by spider bites.

A combination of oncolytic virotherapy and an immune checkpoint inhibitor has shown promise for unresponsive bladder cancer.

We spoke with Dr. Christian Dillon to learn more about degradation-based therapies, the challenges associated with their discovery and how innovative solutions are helping to realize the potential of this promising class of therapeutics.

A consortium of scientists have developed a promising new human monoclonal antibody that appears a step closer to a universal antibody cocktail that works against all strains of SARS-CoV-2.

Finalists for the New Product Award at the SLAS Europe conference showcase cutting-edge innovations in life sciences, evaluated on technical merit, commercial feasibility, originality, impact and market opportunity. Here, we take a look at the six nominees and the products competing for this year’s award.

In this article, we will explore the obstacles that reduce the efficacy of cell-based cancer immunotherapy and strategies to overcome them.

Researchers have used small membrane bubbles – which our cells use to communicate – to deliver targeted cancer treatments to tumors in mouse models, demonstrating reduced tumor growth and extended survival in one model.

Researchers have developed an approach to “deleting” a blood system affected by leukemia while simultaneously building up a new, healthy system with donor blood stem cells.